Specifically, we put Bi-L E7/K14-tTA mice, in which we can temporally regulate expression of the dominant HPV16 oncogene, on either the FancD2-sufficient background or the FancD2-deficient background and chronically treated the mice with estrogen to induce cervical cancer. This evidence concerns the gene FANCD2 and cervical cancer.